These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9036738)

  • 21. [p53--a gene for suppression of tumors?].
    Wustrow TD
    HNO; 1993 May; 41(5):A12-3. PubMed ID: 8335485
    [No Abstract]   [Full Text] [Related]  

  • 22. Alterations of the p16 gene in head and neck cancer: frequency and association with p53, PRAD-1 and HPV.
    Olshan AF; Weissler MC; Pei H; Conway K; Anderson S; Fried DB; Yarbrough WG
    Oncogene; 1997 Feb; 14(7):811-8. PubMed ID: 9047388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Oncogenes and tumor suppressor genes: general features].
    Piccinin S; Vukosavljevic T
    Acta Otorhinolaryngol Ital; 1996 Jun; 16(3 Suppl 54):17-20. PubMed ID: 9036735
    [No Abstract]   [Full Text] [Related]  

  • 24. [Epidemiology of head and neck carcinomas].
    Aupérin A; Hill C
    Cancer Radiother; 2005 Feb; 9(1):1-7. PubMed ID: 15804614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncogenes, molecular biology and the head and neck surgeon.
    Irish JC
    J Otolaryngol; 1992 Dec; 21 Suppl 3():1-20. PubMed ID: 1289578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP; Gazzeri S; Riva C; Reyt E; Brambilla C; Brambilla E
    Anticancer Res; 1998; 18(6B):4741-9. PubMed ID: 9891551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Head and neck squamous cell carcinoma in non-smoking and non-drinking patients with multiple tumors: etiologic significance of p53 and Ki-67 in non-tumorous epithelium.
    Farshadpour F; Hordijk GJ; Koole R; Slootweg PJ
    J Oral Pathol Med; 2008 Oct; 37(9):549-54. PubMed ID: 18331287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The ADH1C polymorphism modifies the risk of squamous cell carcinoma of the head and neck associated with alcohol and tobacco use.
    Peters ES; McClean MD; Liu M; Eisen EA; Mueller N; Kelsey KT
    Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):476-82. PubMed ID: 15734975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic factors for head and neck cancer].
    Fujieda S
    Gan To Kagaku Ryoho; 2001 Apr; 28(4):440-7. PubMed ID: 11329776
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell.
    Takes RP; Baatenburg de Jong RJ; Schuuring E; Litvinov SV; Hermans J; Van Krieken JH
    Anticancer Res; 1998; 18(6B):4793-800. PubMed ID: 9891559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Meta-analysis on the relationship between tobacco smoking, alcohol drinking and p53 alteration in cases with esophageal carcinoma].
    Wang B; Zhang Y; Xu DZ; Wang AH; Zhang L; Sun CS; Li LS
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Sep; 25(9):775-8. PubMed ID: 15555358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathogenesis of head and neck cancers.
    Singh B
    J Surg Oncol; 2008 Jun; 97(8):634-9. PubMed ID: 18493941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L; Stephenson KK; Ling W; Zuo C; Mukunyadzi P; Suen JY; Hanna E; Fan CY
    Mod Pathol; 2003 Sep; 16(9):944-50. PubMed ID: 13679459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P53 expression and polysomies of chromosome 9, 17 in head and neck cancer prognosis.
    Charuruks N; Shin DM; Voravud N; Ro JY; Hong WK; Hittelman WN
    J Med Assoc Thai; 1999 May; 82(5):466-76. PubMed ID: 10443096
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current role of gene therapy in head and neck cancer.
    Ganly I; Soutar DS; Kaye SB
    Eur J Surg Oncol; 2000 Jun; 26(4):338-43. PubMed ID: 10873352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene expression profiles in HPV-infected head and neck cancer.
    Schlecht NF; Burk RD; Adrien L; Dunne A; Kawachi N; Sarta C; Chen Q; Brandwein-Gensler M; Prystowsky MB; Childs G; Smith RV; Belbin TJ
    J Pathol; 2007 Nov; 213(3):283-93. PubMed ID: 17893858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marijuana use and increased risk of squamous cell carcinoma of the head and neck.
    Zhang ZF; Morgenstern H; Spitz MR; Tashkin DP; Yu GP; Marshall JR; Hsu TC; Schantz SP
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1071-8. PubMed ID: 10613339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma.
    Freier K; Joos S; Flechtenmacher C; Devens F; Benner A; Bosch FX; Lichter P; Hofele C
    Cancer Res; 2003 Mar; 63(6):1179-82. PubMed ID: 12649172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.